{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:43:01Z","timestamp":1781091781230,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Community-Academic Scholars Program, University of Illinois Urbana-Champaign"},{"name":"Mary Jane Neer Fund, University of Illinois Urbana-Champaign"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The current fourth wave of the United States opioid overdose epidemic is characterized by the co-use of opioids and stimulants, including illicit opioids and methamphetamine. The co-use of these two drugs, known as \u201cgoofballing,\u201d is associated with higher risk for several adverse outcomes, including more frequent injections, greater health risks, and higher morbidity. Considering these differences, this unique subpopulation of people who inject drugs (PWID) may also have unique unmet needs and harm reduction preferences.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We collected self-reported data from participants (<jats:italic>N<\/jats:italic>\u2009=\u200950) of a syringe services program (SSP), including basic needs and harm reduction preferences. Using bivariate analyses, we examined differences between SSP participants who do and do not co-use illicit opioids and methamphetamine. Co-use was defined as reporting the use of both drugs, which may or may not have been used simultaneously.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In the overall sample, the mean level of need was highest for bus passes or other transportation, a person who can help you get the services you need, medication for opioid use disorder, and a job or job training. Additionally, all participants reported being either interested or very interested in fentanyl test strips, safe consumption sites, delivery of syringe service supplies, and delivery of naloxone. Those who endorsed co-use had a greater need for food, healthcare, substance use disorder treatment, a support person to help them access needed services, and bus passes or transportation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Unmet needs were prevalent, and the desire for more harm reduction services was high among these PWID. Results also suggest people who co-use illicit opioids and methamphetamine may have the greatest unmet needs and desire for additional harm reduction services.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12954-024-01038-2","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T03:40:29Z","timestamp":1718768429000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Unmet needs and harm reduction preferences of syringe services program participants: differences by co-use of illicit opioids and methamphetamine"],"prefix":"10.1186","volume":"21","author":[{"given":"Rachel","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonazzina H.","family":"Sauda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel A.","family":"Hoopsick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,19]]},"reference":[{"issue":"6","key":"1038_CR1","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1007\/s10461-019-02767-3","volume":"24","author":"ST Allen","year":"2020","unstructured":"Allen ST, O\u2019Rourke A, White RH, Smith KC, Weir B, Lucas GM, Sherman SG, Grieb SM. Barriers and facilitators to PrEP use among people who inject drugs in rural Appalachia: a qualitative study. AIDS Behav. 2020;24(6):1942\u201350. https:\/\/doi.org\/10.1007\/s10461-019-02767-3.","journal-title":"AIDS Behav"},{"issue":"2","key":"1038_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s11121-014-0500-4","volume":"16","author":"AA Al-Tayyib","year":"2015","unstructured":"Al-Tayyib AA, Thiede H, Burt RD, Koester S. Unmet health care needs and hepatitis C infection among persons who inject drugs in Denver and Seattle, 2009. Prev Sci. 2015;16(2):330\u201340. https:\/\/doi.org\/10.1007\/s11121-014-0500-4.","journal-title":"Prev Sci"},{"key":"1038_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2019.106037","volume":"98","author":"RD Ashford","year":"2019","unstructured":"Ashford RD, Brown AM, Dorney G, McConnell N, Kunzelman J, McDaniel J, Curtis B. Reducing harm and promoting recovery through community-based mutual aid: characterizing those who engage in a hybrid peer recovery community organization. Addict Behav. 2019;98: 106037. https:\/\/doi.org\/10.1016\/j.addbeh.2019.106037.","journal-title":"Addict Behav"},{"issue":"1","key":"1038_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12954-018-0258-2","volume":"15","author":"RD Ashford","year":"2018","unstructured":"Ashford RD, Curtis B, Brown AM. Peer-delivered harm reduction and recovery support services: initial evaluation from a hybrid recovery community drop-in center and syringe exchange program. Harm Reduct J. 2018;15(1):52. https:\/\/doi.org\/10.1186\/s12954-018-0258-2.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1038_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodol). 1995;57(1):289\u2013300.","journal-title":"J R Stat Soc Ser B (Methodol)"},{"key":"1038_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.abrep.2021.100398","volume":"15","author":"L Brener","year":"2022","unstructured":"Brener L, Caruana T, Broady T, Cama E, Ezard N, Madden A, Treloar C. Addressing injecting related risks among people who inject both opioids and stimulants: findings from an Australian survey of people who inject drugs. Addict Behav Rep. 2022;15: 100398. https:\/\/doi.org\/10.1016\/j.abrep.2021.100398.","journal-title":"Addict Behav Rep"},{"key":"1038_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugpo.2017.06.010","volume":"46","author":"D Ciccarone","year":"2017","unstructured":"Ciccarone D. Fentanyl in the US heroin supply: a rapidly changing risk environment. Int J Drug Policy. 2017;46:107\u201311. https:\/\/doi.org\/10.1016\/j.drugpo.2017.06.010.","journal-title":"Int J Drug Policy"},{"key":"1038_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","volume":"71","author":"D Ciccarone","year":"2019","unstructured":"Ciccarone D. The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis. Int J Drug Policy. 2019;71:183\u20138. https:\/\/doi.org\/10.1016\/j.drugpo.2019.01.010.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1038_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41380-020-00949-3","volume":"26","author":"WM Compton","year":"2021","unstructured":"Compton WM, Valentino RJ, DuPont RL. Polysubstance use in the U.S. opioid crisis. Mol Psychiatry. 2021;26(1):1. https:\/\/doi.org\/10.1038\/s41380-020-00949-3.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"1038_CR10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1080\/00952990.2021.1981919","volume":"48","author":"Z Dai","year":"2022","unstructured":"Dai Z, Abate MA, Groth CP, Rucker T, Kraner JC, Mock AR, Smith GS. Fentanyl and other opioid involvement in methamphetamine-related deaths. Am J Drug Alcohol Abuse. 2022;48(2):226\u201334. https:\/\/doi.org\/10.1080\/00952990.2021.1981919.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"48","key":"1038_CR11","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.15585\/mmwr.mm6448a3","volume":"64","author":"DC Des Jarlais","year":"2015","unstructured":"Des Jarlais DC, Nugent A, Solberg A, Feelemyer J, Mermin J, Holtzman D. Syringe service programs for persons who inject drugs in urban, suburban, and rural areas\u2014United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64(48):1337\u201341. https:\/\/doi.org\/10.15585\/mmwr.mm6448a3.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1038_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2019.01052","volume":"10","author":"D Eddie","year":"2019","unstructured":"Eddie D, Hoffman L, Vilsaint C, Abry A, Bergman B, Hoeppner B, Weinstein C, Kelly JF. Lived experience in new models of care for substance use disorder: a systematic review of peer recovery support services and recovery coaching. Front Psychol. 2019;10: 458901.","journal-title":"Front Psychol"},{"key":"1038_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104222","author":"AT Estadt","year":"2023","unstructured":"Estadt AT, Miller WC, Kline D, Whitney BM, Young AM, Todd Korthuis P, Stopka TJ, Feinberg J, Zule WA, Pho MT, Friedmann PD, Westergaard RP, Eagen KV, Seaman A, Ma J, Go VF, Lancaster KE. Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communities. Int J Drug Policy. 2023. https:\/\/doi.org\/10.1016\/j.drugpo.2023.104222.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1038_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12954-024-00936-9","volume":"21","author":"AT Estadt","year":"2024","unstructured":"Estadt AT, White BN, Ricks JM, Lancaster KE, Hepler S, Miller WC, Kline D. The impact of fentanyl on state- and county-level psychostimulant and cocaine overdose death rates by race in Ohio from 2010 to 2020: a time series and spatiotemporal analysis. Harm Reduct J. 2024;21(1):13. https:\/\/doi.org\/10.1186\/s12954-024-00936-9.","journal-title":"Harm Reduct J"},{"issue":"12","key":"1038_CR15","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1111\/add.16318","volume":"118","author":"J Friedman","year":"2023","unstructured":"Friedman J, Shover CL. Charting the fourth wave: geographic, temporal, race\/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010\u20132021. Addiction. 2023;118(12):2477\u201385. https:\/\/doi.org\/10.1111\/add.16318.","journal-title":"Addiction"},{"issue":"2","key":"1038_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/ajad.13115","volume":"30","author":"SN Glick","year":"2021","unstructured":"Glick SN, Klein KS, Tinsley J, Golden MR. Increasing Heroin-Methamphetamine (Goofball) use and related morbidity among Seattle area people who inject drugs. Am J Addict. 2021;30(2):183\u201391. https:\/\/doi.org\/10.1111\/ajad.13115.","journal-title":"Am J Addict"},{"issue":"1","key":"1038_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12954-022-00672-y","volume":"19","author":"P Godkhindi","year":"2022","unstructured":"Godkhindi P, Nussey L, O\u2019Shea T. \u201cThey\u2019re causing more harm than good\u201d: a qualitative study exploring racism in harm reduction through the experiences of racialized people who use drugs. Harm Reduct J. 2022;19(1):96. https:\/\/doi.org\/10.1186\/s12954-022-00672-y.","journal-title":"Harm Reduct J"},{"key":"1038_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2022.108722","volume":"138","author":"R Hassan","year":"2022","unstructured":"Hassan R, Roland KB, Hernandez B, Goldman L, Evans KN, Gaul Z, Agnew-Brune C, Buchacz K, Fukuda HD. A qualitative study of service engagement and unmet needs among unstably housed people who inject drugs in Massachusetts. J Subst Abuse Treat. 2022;138: 108722. https:\/\/doi.org\/10.1016\/j.jsat.2022.108722.","journal-title":"J Subst Abuse Treat"},{"key":"1038_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.859563","volume":"13","author":"HM Hazani","year":"2022","unstructured":"Hazani HM, Naina Mohamed I, Muzaimi M, Mohamed W, Yahaya MF, Teoh SL, Pakri Mohamed RM, Mohamad Isa MF, Abdulrahman SM, Ramadah R, Kamaluddin MR, Kumar J. Goofballing of opioid and methamphetamine: the science behind the deadly cocktail. Front Pharmacol. 2022;13: 859563. https:\/\/doi.org\/10.3389\/fphar.2022.859563.","journal-title":"Front Pharmacol"},{"key":"1038_CR20","first-page":"1","volume":"406","author":"H Hedegaard","year":"2021","unstructured":"Hedegaard H, Mini\u00f1o AM, Warner M. Co-involvement of opioids in drug overdose deaths involving cocaine and psychostimulants. NCHS Data Brief. 2021;406:1\u20138.","journal-title":"NCHS Data Brief"},{"issue":"4","key":"1038_CR21","doi-asserted-by":"publisher","first-page":"416","DOI":"10.2105\/AJPH.2022.307212","volume":"113","author":"RA Hoopsick","year":"2023","unstructured":"Hoopsick RA, Andrew Yockey R. Methamphetamine-related mortality in the United States: co-involvement of heroin and fentanyl, 1999\u20132021. Am J Public Health. 2023;113(4):416\u20139. https:\/\/doi.org\/10.2105\/AJPH.2022.307212.","journal-title":"Am J Public Health"},{"issue":"Pt 2","key":"1038_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2021.106541","volume":"152","author":"RA Jenkins","year":"2021","unstructured":"Jenkins RA. The fourth wave of the US opioid epidemic and its implications for the rural US: a federal perspective. Prev Med. 2021;152(Pt 2): 106541. https:\/\/doi.org\/10.1016\/j.ypmed.2021.106541.","journal-title":"Prev Med"},{"issue":"2","key":"1038_CR23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0376-8716(01)00126-0","volume":"64","author":"DB Kandel","year":"2001","unstructured":"Kandel DB, Huang F-Y, Davies M. Comorbidity between patterns of substance use dependence and psychiatric syndromes. Drug Alcohol Depend. 2001;64(2):233\u201341. https:\/\/doi.org\/10.1016\/S0376-8716(01)00126-0.","journal-title":"Drug Alcohol Depend"},{"key":"1038_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jsat.2019.08.016","volume":"106","author":"S Kawasaki","year":"2019","unstructured":"Kawasaki S, Francis E, Mills S, Buchberger G, Hogentogler R, Kraschnewski J. Multi-model implementation of evidence-based care in the treatment of opioid use disorder in Pennsylvania. J Subst Abuse Treat. 2019;106:58\u201364. https:\/\/doi.org\/10.1016\/j.jsat.2019.08.016.","journal-title":"J Subst Abuse Treat"},{"issue":"9","key":"1038_CR25","doi-asserted-by":"publisher","first-page":"991","DOI":"10.2105\/ajph.2023.307337","volume":"113","author":"D Kline","year":"2023","unstructured":"Kline D, Bunting AM, Hepler SA, Rivera-Aguirre A, Krawczyk N, Cerda M. State-level history of overdose deaths involving stimulants in the United States, 1999\u20132020. Am J Public Health. 2023;113(9):991\u20139. https:\/\/doi.org\/10.2105\/ajph.2023.307337.","journal-title":"Am J Public Health"},{"issue":"8","key":"1038_CR26","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.26544","volume":"5","author":"PT Korthuis","year":"2022","unstructured":"Korthuis PT, Cook RR, Foot CA, Leichtling G, Tsui JI, Stopka TJ, Leahy J, Jenkins WD, Baker R, Chan B, Crane HM, Cooper HL, Feinberg J, Zule WA, Go VF, Estadt AT, Nance RM, Smith GS, Westergaard RP, Young AM. Association of methamphetamine and opioid use with nonfatal overdose in rural communities. JAMA Netw Open. 2022;5(8): e2226544. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.26544.","journal-title":"JAMA Netw Open"},{"issue":"10","key":"1038_CR27","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/pds.4869","volume":"28","author":"CA Mallama","year":"2019","unstructured":"Mallama CA, Trinidad JP, Swain RS, Zhao Y, Woods C, McAninch JK. A comparison of opioid-involved fatalities captured in the National Poison Data System to data derived from US death certificate literal text. Pharmacoepidemiol Drug Saf. 2019;28(10):1377\u201385. https:\/\/doi.org\/10.1002\/pds.4869.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"1038_CR28","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/add.15217","volume":"116","author":"A Palmer","year":"2021","unstructured":"Palmer A, Higgs P, Scott N, Agius P, Maher L, Dietze P. Prevalence and correlates of simultaneous, multiple substance injection (co-injection) among people who inject drugs in Melbourne. Aust Addict. 2021;116(4):876\u201388. https:\/\/doi.org\/10.1111\/add.15217.","journal-title":"Aust Addict"},{"issue":"3","key":"1038_CR29","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/07347324.2011.587731","volume":"29","author":"WL White","year":"2011","unstructured":"White WL, Kelly JF. Alcohol\/Drug\/Substance \u201cAbuse\u201d: the history and (Hopeful) demise of a pernicious label. Alcohol Treat Q. 2011;29(3):317\u201321. https:\/\/doi.org\/10.1080\/07347324.2011.587731.","journal-title":"Alcohol Treat Q"},{"key":"1038_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.drugpo.2019.04.010","volume":"70","author":"M Zoorob","year":"2019","unstructured":"Zoorob M. Fentanyl shock: the changing geography of overdose in the United States. Int J Drug Policy. 2019;70:40\u20136. https:\/\/doi.org\/10.1016\/j.drugpo.2019.04.010.","journal-title":"Int J Drug Policy"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-024-01038-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-024-01038-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-024-01038-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T19:06:51Z","timestamp":1718824011000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-024-01038-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,19]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1038"],"URL":"https:\/\/doi.org\/10.1186\/s12954-024-01038-2","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,19]]},"assertion":[{"value":"11 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"119"}}